Inspectors Find Illegal Marketing by Herbal Drugmaker Quanjian

TRENDING: AI Companies’ Success Lies in the Apps, Bain’s China Chairman Says; AI Companies’ Success Lies in the Apps, Bain’s China Chairman Says; Unitree Shares Decline as Founder Flags Limits of Humanoid Robots

LATEST: YMTC Moves Closer to Shanghai IPO; Unitree Shares Decline as Founder Flags Limits of Humanoid Robots; AI Companies’ Success Lies in the Apps, Bain’s China Chairman Says; China’s LandSpace Recovers Booster in Reusable Rocket Breakthrough; Spacecom Raises $1.94 billion in Bet on China’s Starlink Rival; U.S. Appeals Court Orders Review of Pentagon’s DJI Designation; Unitree to Debut at 61 Billion Yuan Valuation in Closely Watched Shanghai IPO; Alibaba to Sell Gaming Unit as It Sharpens AI Focus; China’s DJI and Arashi Vision Escalate Battle for 360-Camera Market; Didi Swings to Quarterly Profit, but Overseas Push Weighs on First-Half Results; Z.AI Pushes AI Model With Coding Edge to Rival Anthropic, Open AI; DeepSeek Launches V4-Pro and Raises API Prices by as Much as 1,100%; Tencent Shares Fall as AI Spending Squeezes Profit; Honor’s New Smartphone Doubles as a Robotic Camera Operator; YMTC Overtakes Kioxia by Shipments to Rank No. 3 in Global NAND Market; ModelBest Begins Pre-IPO Tutoring as On-Device AI Competition Heats Up; U.S. Proposes Ban on Domestic Drone Maker Over Alleged DJI Ties; Manus Cuts Ties With Meta as Tencent Emerges as Top Backer; Cautious Regulators Steer China’s Flying Vehicle Industry to Prioritize Cargo Over Commuters; Alibaba Opens Qwen Platform to Outside Developers in Push to Build AI-Agent Ecosystem

By Han Wei / Dec 29, 2018 02:40 AM / Business & Tech

Photo: VCG

An initial investigation of herbal medicines and health foods producer Quanjian Group Co. Ltd. found that the company committed violations by exaggerating the benefits of its products, the state broadcaster China Central Television reported Friday.

A formal investigation has been initiated against Quanjian by the Tianjin city market regulator on allegations of violating market competition law, said the report.

Tianjin-based Quanjian has been under public scrutiny since Dingxiangyuan, an online health news portal, published an article Tuesday reporting that the company exaggerated the benefits of its products, which contributed to the 2015 death of a 4-year-old with cancer. Tianjin authorities sent inspectors to the company after the report went viral.

Quanjian also faces questions on whether it was involved in pyramid sales, which are banned in China. An official on the inspection team said the probe is still underway, according to the CCTV report.

Share this article

Open WeChat and scan the QR code